Skip to content

Depression: all studies

Page 235 of 1,034: studies 2,341 to 2,350 of 10,336, newest first. Back to the depression overview

Research

Effects of Mindfulness Training on Emotion Regulation in Patients With Depression: Reduced Dorsolateral Prefrontal Cortex Activation Indexes Early Beneficial Changes

Psychosomatic Medicine May 5, 2021 Thorsten Barnhofer, Tim Jonas Reeß, Maria Fißler et al. 24 citations

OBJECTIVE: Mindfulness-based interventions (MBIs) have been found to be a promising approach for the treatment of recurrent courses of depression. However, little is known about their neural mechanisms. This functional magnetic resonance imaging study set out to investigate activation changes in corticolimbic regions during implicit emotion regulation. METHODS: Depressed patients with a...

DOI: 10.1097/psy.0000000000000955 (opens in new tab) Mindfulness Dorsolateral prefrontal cortex Cognitive reappraisal Amygdala +4

A utilização terapêutica da psilocibina como coadjuvante no tratamento do transtorno depressivo maior: uma revisão narrativa de literatura / The therapeutic use of psilocybin as an adjunct in the treatment of major depressive disorder: a narrative literature review

Brazilian Journal of Health Review May 3, 2021 Fabiana Venancio Santana Silva, Alexandre Libanio Silva Reis, Amanda Prazeres Costa et al.

Dados da Organização Mundial de Saúde (OMS) informam que a depressão circunda entre as doenças mais incapacitantes do mundo, estimando-se que mais de 300 milhões de pessoas sofram com esta patologia. A psilocibina é um princípio ativo extraído do cogumelo do gênero Psilocybe de natureza química semelhante ao neurotransmissor serotonina (5- hidroxitriptamina) e a sua ação fisiológica em humanos...

Magnesium in Ketamine Administration in Treatment-Resistant Depression

Pharmaceuticals May 3, 2021 Natalia Górska, Wiesław Jerzy Cubała, Jakub Słupski et al. 2 citations

Relationship between depression and magnesium levels is reported. This observational study examined whether serum magnesium concentration change over time of ketamine treatment course, also whether association between magnesium concentrations and treatment response measured with Montgomery-Åsberg Depression Rating Scale (MADRS) score occurs. Moreover, interlink between changes in Young Mania...

DOI: 10.3390/ph14050430 (opens in new tab) Ketamine Magnesium Depression economics Mania +7

Retracing our steps to understand ketamine in depression: A focused review of hypothesized mechanisms of action

Mental Health Clinician May 1, 2021 Madison N. Irwin, Amy VandenBerg

AbstractIntroductionMDD represents a significant burden worldwide, and while a number of approved treatments exist, there are high rates of treatment resistance and refractoriness. Ketamine, an N-methyl-d-aspartate receptor (NMDAR) antagonist, is a novel, rapid-acting antidepressant, however the mechanisms underlying the efficacy of ketamine are not well understood and many other mechanisms...

Positive effects of psychedelics on depression and wellbeing scores in individuals reporting an eating disorder.

Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity May 1, 2021 M J Spriggs, Hannes Kettner, R L Carhart-Harris

Psychedelic therapy is showing promise for a broad range of mental health conditions, indicative of a transdiagnostic action. While the efficacy of symptom-focused treatments for eating disorders (EDs) is limited, improved mental health and psychological wellbeing are thought to contribute to greater treatment outcomes. This study provides the first quantitative exploration of the psychological...

DOI: 10.1007/s40519-020-01000-8 (opens in new tab) Full text (opens in new tab) Anorexia Binge eating disorder Bulimia Longitudinal +2

Ayahuasca prevents oxidative stress in a rat model of depression elicited by unpredictable chronic mild stress

LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) May 1, 2021 21 citations

ABSTRACT Background: Depression is a highly disabling common mental disorder and, due to its multifactorial nature, the development of effective therapies is challenging and of great relevance. Ayahuasca (AYA), an entheogenic traditional beverage, has emerged as an alternative for antidepressant treatment, however, AYA preclinical and clinical trials are still incipient. Objectives: This...

Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success?

Frontiers in Neuroscience April 30, 2021 E. Carboni, A. Carta, Elena Carboni et al. 28 citations

Repurposing ketamine in the therapy of depression could well represent a breakthrough in understanding the etiology of depression. Ketamine was originally used as an anesthetic drug and later its use was extended to other therapeutic applications such as analgesia and the treatment of addiction. At the same time, the abuse of ketamine as a recreational drug has generated a concern for its...

Ketamine for Bipolar Depression: A Systematic Review

The International Journal of Neuropsychopharmacology April 30, 2021 Anees Bahji, Carlos A. Zarate, Gustavo Vazquez 62 citations

Abstract Background Ketamine appears to have a therapeutic role in certain mental disorders, most notably unipolar major depressive disorder. However, its efficacy in bipolar depression is less clear. This study aimed to assess the efficacy and tolerability of ketamine for bipolar depression. Methods We conducted a systematic review of experimental studies using ketamine for the treatment of...

Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression

Advances in Therapy April 30, 2021 Eric P. Mcmullen, Yena Lee, Orly Lipsitz et al.

Ketamine treatment is capable of significant and rapid symptom improvement in adults with treatment-resistant depression (TRD). A limitation of ketamine treatment in TRD is the relatively short duration of time to relapse (e.g., median 2–4 weeks). The objective of the systematic review herein is to identify strategies capable of prolonging the acute efficacy of ketamine in adults with TRD....

The Effectiveness of Mindfulness-Based Stress Reduction Treatment on Depression and Optimism among Women with Breast Cancer during Chemotherapy

International Journal of Health Studies April 27, 2021 Shariat Homayoon, Tanaz Dabiri, Maryam Ghorbani Nezhad et al. 1 citation

Background: A breast cancer diagnosis can be a disturbing and stressful time for women. This study aimed to determine the effectiveness of mindfulness-based stress reduction treatment depression and optimism during chemotherapy among women with breast cancer. Methods: This study was a quasi-experimental one with a group of pre-test, post-test, and controls. In this study, 26 women with breast...